Cargando…

Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer

Estrogen signaling influences the development and progression of ovarian tumors, but the underlying mechanisms are not well understood. In a previous study we demonstrated that impairment of estrogen receptor alpha (ERα)-mediated olfactomedin 4 (OLFM4) expression promotes the malignant progression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Hanyu, Tian, Tian, Liang, Shuang, Liu, Xubin, Shen, Hongwei, Xia, Meng, Liu, Xingyang, Zhang, Wenhui, Wang, Liantang, Chen, Shangwu, Yu, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891143/ https://www.ncbi.nlm.nih.gov/pubmed/26871282 http://dx.doi.org/10.18632/oncotarget.7236

Ejemplares similares

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma
por: Duan, Chao, et al.
Publicado: (2014)

Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction
por: Zhang, Rui, et al.
Publicado: (2015)

miR-486 is modulated by stretch and increases ventricular growth
por: Lange, Stephan, et al.
Publicado: (2019)

miR-486 Responds to Apoptosis and Autophagy by Repressing SRSF3 Expression in Ovarian Granulosa Cells of Dairy Goats
por: Liu, Shujuan, et al.
Publicado: (2023)

LncRNA MIR503HG inhibits cell migration and invasion via miR‐103/OLFM4 axis in triple negative breast cancer
por: Fu, Jia, et al.
Publicado: (2019)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Significance of differential expression of OLFM4 in the development of endometrial adenocarcinoma
por: Huang, Di, et al.
Publicado: (2022)

miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1
por: Li, Chenyang, et al.
Publicado: (2021)

The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma
por: Tomioka, Yuya, et al.
Publicado: (2023)

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022)

miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2017)

Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”
por: Wang, Hao, et al.
Publicado: (2021)

miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2017)

miR-486-5p expression is regulated by DNA methylation in osteosarcoma
por: Namløs, Heidi M., et al.
Publicado: (2022)

miR-486 is essential for muscle function and suppresses a dystrophic transcriptome
por: Samani, Adrienne, et al.
Publicado: (2022)

miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway
por: He, Ming, et al.
Publicado: (2023)

MiR-486-3p inhibits the proliferation, migration and invasion of retinoblastoma cells by targeting ECM1
por: Yang, Hongwei, et al.
Publicado: (2020)

Down-regulation of miR-486-5p expression inhibits the proliferation and invasion of human extravillous trophoblasts, and decreased peripheral plasma miR-486-5p level is associated with human early pregnancy loss: Role of miR-486-5p in human early pregnancy loss
por: Gu, Yan, et al.
Publicado: (2023)

Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
por: Wang, Anqi, et al.
Publicado: (2020)

MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome
por: Narducci, M G, et al.
Publicado: (2011)

Silencing of miR-486 alleviates LPS-stimulated inflammatory response of macrophages through targeting SIRT1
por: Huang, Jie, et al.
Publicado: (2019)

miR-486-5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9
por: Wei, Weiwei, et al.
Publicado: (2021)

Diagnostic and prognostic value of miR-486-5p, miR-451a, miR-21-5p and monocyte to high-density lipoprotein cholesterol ratio in patients with acute myocardial infarction
por: Xu, Liwenjing, et al.
Publicado: (2022)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma
por: Chen, Zujian, et al.
Publicado: (2017)

miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma
por: Chen, Zujian, et al.
Publicado: (2017)

MiR-486 Regulates Lactation and Targets the PTEN Gene in Cow Mammary Glands
por: Li, Dan, et al.
Publicado: (2015)

Expression and Prognostic Value of miR-486-5p in Patients with Gastric Adenocarcinoma
por: Chen, Hui, et al.
Publicado: (2015)

miR-486-5p: A Prognostic Biomarker for Chronic Myeloid Leukemia
por: Ninawe, Anupama, et al.
Publicado: (2021)

MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis
por: Jiang, Min, et al.
Publicado: (2018)

Tanshinone IIA protects against chronic obstructive pulmonary disease via exosome-shuttled miR-486-5p
por: Tian, Dongdong, et al.
Publicado: (2022)

Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p
por: Zhao, Hongmei, et al.
Publicado: (2021)

miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma
por: Liu, Chengxia, et al.
Publicado: (2016)

MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation
por: Tang, Qisheng, et al.
Publicado: (2020)

Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms
por: Li, Chunmei, et al.
Publicado: (2018)

MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2017)

MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
por: Jiang, Jingwei, et al.
Publicado: (2018)

miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer
por: Gao, Zhao-Jia, et al.
Publicado: (2020)

miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
por: Ji, Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eg4ibrsgsjf74e5cjg8s6ea6eu